These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35155161)

  • 1. Predicting Radioresistant Biomarkers in Nasopharyngeal Carcinoma Patients Via Protein-Protein Interaction Network Analysis.
    Rezaei Tavirani M; Okhovatian F; Rostami Nejad M; Arjmand B; Razzaghi Z
    J Lasers Med Sci; 2021; 12():e76. PubMed ID: 35155161
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasopharyngeal Carcinoma Protein Interaction Mapping Analysis via Proteomic Approaches.
    Zamanian Azodi M; Rezaei Tavirani M; Rezaei Tavirani M; Vafaee R; Rostami-Nejad M
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):845-851. PubMed ID: 29582644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction Network Prediction and Analysis of Anorexia Nervosa.
    Rezaei Tavirani M; Rezaei Tavirani M; Vafaee R
    Iran J Child Neurol; 2019; 13(3):45-54. PubMed ID: 31327968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.
    Zhang G; Zhang K; Li C; Li Y; Li Z; Li N; Zhou Q; Shen L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma.
    Zhao H; Chang A; Ling J; Zhou W; Ye H; Zhuo X
    3 Biotech; 2020 Dec; 10(12):511. PubMed ID: 33184596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
    Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
    Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells.
    Li XH; Qu JQ; Yi H; Zhang PF; Yi HM; Wan XX; He QY; Ye X; Yuan L; Zhu JF; Li JY; Xiao ZQ
    PLoS One; 2014; 9(1):e87767. PubMed ID: 24498188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
    Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
    Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
    Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
    Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.
    Zamanian Azodi M; Arjmand B; Zali A; Razzaghi M
    Gastroenterol Hepatol Bed Bench; 2020; 13(4):367-373. PubMed ID: 33244380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
    Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
    Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Therapy in Patients With Brain Cancer: Post-proteomics Interpretation.
    Asadzadeh-Aghdaei H; Okhovatian F; Razzaghi Z; Heidari M; Vafaee R; Nikzamir A
    J Lasers Med Sci; 2019; 10(Suppl 1):S59-S63. PubMed ID: 32021675
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
    Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
    Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma.
    Zhang MX; Wang L; Zeng L; Tu ZW
    Front Oncol; 2020; 10():605777. PubMed ID: 33604288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks.
    Guo Y; Zhu XD; Qu S; Li L; Su F; Li Y; Huang ST; Li DR
    Int J Oncol; 2012 Jan; 40(1):85-92. PubMed ID: 21874234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
    Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y
    BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
    Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
    Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review: Proteomics in Nasopharyngeal Carcinoma.
    Chen ZT; Liang ZG; Zhu XD
    Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Radiation Versus Conventional Fractionated Radiation: A Network Analysis.
    Arjmand B; Rezaei-Tavirani M; Hamzeloo-Moghadam M; Razzaghi Z; Khodadoost M; Okhovatian F; Zamanian-Azodi M; Ansari M
    J Lasers Med Sci; 2022; 13():e39. PubMed ID: 36743138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.